Shuntaro Ikeda

Contribution of non-cardiomyocyte apoptosis to cardiac remodelling that occurs in the transition from compensated hypertrophy to heart failure in spontaneously hypertensive rats.

M. Hamada, S. Ikeda, K. Hiwada, 1999, Clinical science.

Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy.

H. Okayama, M. Hamada, Y. Shigematsu, 1997, Circulation.

Time-course changes in left ventricular geometry and function during the development of hypertension in Dahl salt-sensitive rats.

M. Hamada, Y. Shigematsu, S. Ikeda, 2000, Hypertension research : official journal of the Japanese Society of Hypertension.

Contribution of the long-term care insurance certificate for predicting 1-year all-cause readmission compared with validated risk scores in elderly patients with heart failure

J. Higaki, A. Ogimoto, S. Ikeda, 2016, Open Heart.